| Kalamazoo Tms & Behavioral Health | |
|
5390 Lovers Ln Third Floor Portage MI 49002 | |
| (269) 381-6950 | |
| (269) 381-6954 |
| Full Name | Kalamazoo Tms & Behavioral Health |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 5390 Lovers Ln, Portage, Michigan |
| Authorized Official Name and Position | Ruqiya Tareen (MEDICAL DIRECTOR) |
| Authorized Official Contact | 2693816950 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Kalamazoo Tms & Behavioral Health 5930 Lovers Ln Third Floor Portage MI 49002-1673 Ph: (269) 381-6950 | Kalamazoo Tms & Behavioral Health 5390 Lovers Ln Third Floor Portage MI 49002 Ph: (269) 381-6950 |
| NPI Number | 1114219227 |
|---|---|
| Provider Enumeration Date | 05/07/2011 |
| Last Update Date | 02/16/2016 |
| Medicare PECOS PAC ID | 7911175948 |
|---|---|
| Medicare Enrollment ID | O20110719000359 |
News Archive
Sodium channels are implicated in many serious conditions such as heart disease, epilepsy and pain, making them an important potential target for drug therapies. Unfortunately, there is still much scientists do not know about the molecules.
ZeroNines® Technology, Inc. announced the launch of ZenVault™ Medical, a Personal Health Record portal (PHR) that gives consumers instant, secure, private access to their medical records online. ZenVault Medical was specifically designed to address the public's concerns over data security, privacy, convenience, and expense associated with the national push to convert from traditional paper to digital medical records.
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will be exhibiting for the first time in The Netherlands its new patient dedicated arterial blood gas system. Attendees of the NVIC (Dutch Intensive Care Society) Najaarscongres 2015, in Utrecht from 17-18th September will be able to find out how the new Proxima System supports rapid and frequent measurements without leaving the patient's bedside.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
The results of the Phase 2 program sponsored by Iroko Pharmaceuticals to develop novel, lower-dose formulations of a widely used class of pain medicines will be reported November 7th at the annual meeting of the American College of Rheumatology in Chicago.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114219227 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4301078095 (Michigan) | Primary |
| Provider Name | Ruqiya Tareen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1598724122 PECOS PAC ID: 5092742239 Enrollment ID: I20050720000240 |
News Archive
Sodium channels are implicated in many serious conditions such as heart disease, epilepsy and pain, making them an important potential target for drug therapies. Unfortunately, there is still much scientists do not know about the molecules.
ZeroNines® Technology, Inc. announced the launch of ZenVault™ Medical, a Personal Health Record portal (PHR) that gives consumers instant, secure, private access to their medical records online. ZenVault Medical was specifically designed to address the public's concerns over data security, privacy, convenience, and expense associated with the national push to convert from traditional paper to digital medical records.
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will be exhibiting for the first time in The Netherlands its new patient dedicated arterial blood gas system. Attendees of the NVIC (Dutch Intensive Care Society) Najaarscongres 2015, in Utrecht from 17-18th September will be able to find out how the new Proxima System supports rapid and frequent measurements without leaving the patient's bedside.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
The results of the Phase 2 program sponsored by Iroko Pharmaceuticals to develop novel, lower-dose formulations of a widely used class of pain medicines will be reported November 7th at the annual meeting of the American College of Rheumatology in Chicago.
› Verified 4 days ago
| Provider Name | Pamela M Bryant |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669744660 PECOS PAC ID: 5193986099 Enrollment ID: I20120420000353 |
News Archive
Sodium channels are implicated in many serious conditions such as heart disease, epilepsy and pain, making them an important potential target for drug therapies. Unfortunately, there is still much scientists do not know about the molecules.
ZeroNines® Technology, Inc. announced the launch of ZenVault™ Medical, a Personal Health Record portal (PHR) that gives consumers instant, secure, private access to their medical records online. ZenVault Medical was specifically designed to address the public's concerns over data security, privacy, convenience, and expense associated with the national push to convert from traditional paper to digital medical records.
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will be exhibiting for the first time in The Netherlands its new patient dedicated arterial blood gas system. Attendees of the NVIC (Dutch Intensive Care Society) Najaarscongres 2015, in Utrecht from 17-18th September will be able to find out how the new Proxima System supports rapid and frequent measurements without leaving the patient's bedside.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
The results of the Phase 2 program sponsored by Iroko Pharmaceuticals to develop novel, lower-dose formulations of a widely used class of pain medicines will be reported November 7th at the annual meeting of the American College of Rheumatology in Chicago.
› Verified 4 days ago
News Archive
Sodium channels are implicated in many serious conditions such as heart disease, epilepsy and pain, making them an important potential target for drug therapies. Unfortunately, there is still much scientists do not know about the molecules.
ZeroNines® Technology, Inc. announced the launch of ZenVault™ Medical, a Personal Health Record portal (PHR) that gives consumers instant, secure, private access to their medical records online. ZenVault Medical was specifically designed to address the public's concerns over data security, privacy, convenience, and expense associated with the national push to convert from traditional paper to digital medical records.
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will be exhibiting for the first time in The Netherlands its new patient dedicated arterial blood gas system. Attendees of the NVIC (Dutch Intensive Care Society) Najaarscongres 2015, in Utrecht from 17-18th September will be able to find out how the new Proxima System supports rapid and frequent measurements without leaving the patient's bedside.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
The results of the Phase 2 program sponsored by Iroko Pharmaceuticals to develop novel, lower-dose formulations of a widely used class of pain medicines will be reported November 7th at the annual meeting of the American College of Rheumatology in Chicago.
› Verified 4 days ago
Seed To Tree Counseling & Wellness Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8150 Mayfield St, Portage, MI 49002 Phone: 269-377-2485 | |
Michigan Integrated Therapies Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8080 Moorsbridge Rd Ste 102, Portage, MI 49024 Phone: 269-795-6681 | |
Millicent M Perkins Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5930 Lovers Ln, Portage, MI 49002 Phone: 269-344-9490 Fax: 269-344-8696 | |
Maternal Hope Counseling Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 640 Romence Rd Ste 211a, Portage, MI 49024 Phone: 269-359-7300 | |
Ascension Medical Group Promed Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8001 Angling Rd, Portage, MI 49024 Phone: 269-321-7090 | |
Southwest Michigan Behavioral Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5250 Lovers Ln Ste 200, Portage, MI 49002 Phone: 800-676-0423 | |
Michael V Bloom Phd Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7920 Kirkland Ct, Portage, MI 49024 Phone: 269-345-0669 Fax: 269-345-5354 |